Pingxiao capsules

Pingxiao capsules (also known as Canelim or Canlim) is an approved traditional Chinese medicine (TCM) herbal formula developed and manufactured by Xi'an C.P. Pharmaceutical. It is widely used in China as an adjuvant therapy alongside conventional chemotherapy, radiotherapy, or surgery for various malignancies, including breast, lung, esophageal, and gastrointestinal cancers, as well as benign proliferative conditions like breast hyperplasia and uterine fibroids. The formula consists of eight primary ingredients: Curcuma wenyujin, Strychnos nux-vomica, Agrimonia pilosa, Toxicodendron vernicifluum, Trogopterus feces, alum, potassium nitrate, and Citrus aurantium. Pingxiao capsules exert anti-tumor effects by inducing cancer cell apoptosis, inhibiting tumor angiogenesis, suppressing tumor cell proliferation and metastasis, and modulating the immune response. Additionally, it helps mitigate chemotherapy-induced toxicities, such as bone marrow suppression and leukopenia.